Skip to main content

Way to go Ticketmaster!

This is from an e-newsletter put out by the National Federation of the Blind. It's always nice to be able to give a company kudos for making themselves accessable to everyone!

Ticketmaster Makes Web Site Fully Accessible and Fan-Friendly to Blind Users



The NFB also announced a cooperative agreement with Ticketmaster, the global event ticketing leader and one of the world’s top five eCommerce sites, to make its Web site fully accessible to the blind. Under the agreement, the Ticketmaster Web site will be made fully accessible to blind users utilizing screen access technology by December 31, 2011. Screen access technology converts what is on the computer screen into synthesized speech or Braille.






Pursuant to the agreement, Ticketmaster will develop a comprehensive accessibility program that will include the development of an accessibility guidelines manual, as well as the appointment of both an accessibility coordinator and an accessibility committee.






Additionally, Ticketmaster will continue to work with officials of the National Federation of the Blind to ensure that the Ticketmaster services remain accessible to the blind. Ticketmaster will submit its Web site to the NFB Nonvisual Accessibility (NFB-NVA) Web Certification program, a rigorous procedure by which Web sites and applications that have made efforts to be accessible to the blind can be identified and recognized. The NFB-NVA Web Certification program continually monitors participating sites to ensure that they remain compliant with certification criteria. If a site remains accessible, its certification is renewed on an annual or a version basis. If accessibility issues arise, the National Federation of the Blind will work with the site developers to remedy them.


Find out more in the NFB’s press releases about the LSAC settlement and the Ticketmaster cooperative agreement.






Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria